非心血管血性缺血性中风的抗血栓治疗:目前的证据和未来的方向
Brett Cucchiara1, Jean M Connors2, Alejandro A Rabinstein3
1Department of Neurology, University of Pennsylvania, Philadelphia (B.C.).
Stroke
|March 13, 2026
概括
通过XIa因子抑制剂的双通道抑制表明,它有望预防复发的非心血管血栓性中风,而不会增加出血风险. 这种方法可能会为当前的抗血栓治疗提供更安全的替代方案.
科学领域:
- 神经学 神经学
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 抗血小板单一治疗对于非心血管血栓性中风的二次中风预防是有效的.
- 双抗血小板治疗在急性轻度中风或短暂缺血性发作中优于单一治疗.
- 积极的抗血栓策略往往会增加出血风险,而不会显著减少缺血事件.
研究的目的:
- 审查目前用于预防非心血管栓塞性中风的二次中风的抗血栓治疗方法.
- 讨论新兴的XI/XIa因子抑制剂用于预防中风.
- 为了强调海洋中风试验的意义.
主要方法:
- 对预防中风的抗血栓治疗进行多项临床试验的综述.
- 对新型XI/XIa因子抑制剂的已完成和正在进行的试验数据的分析.
- 评估双通道抑制策略.
主要成果:
- XI/XIa因子抑制剂可能会将血液静止与病理性血栓脱.
- 海洋中风试验证明了双通道抑制 (asundexian + 抗血小板) 的积极结果.
- 新型药物旨在增强中风的预防,而不会增加出血.
结论:
- XI/XIa因子抑制剂在抗血栓治疗中是一个有希望的进步.
- 双通道抑制为改善二次中风预防提供了潜力.
- 对新型药物的进一步研究对于优化中风预防策略至关重要.
相关概念视频
Venous Thrombosis III: Interprofessional Care
449
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
449
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.6K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.6K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.2K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.2K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.4K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.4K
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
614
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
614
Peripheral Artery Disease III: Interprofessional Care
494
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
494


